![[The Fix] Standardisation of Healthcare AI](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,quality=80,format=auto,width=720,onerror=redirect/uploads/asset/file/fad12a30-4047-43af-b071-b7d2126269b9/T_personal_shared_-_Frame_539__1_.jpg?t=1786522749)
Welcome to another exciting week from the Healthcare and Life Sciences ecosystem! We've got a packed newsletter full of insights, events, and inspiring stories from the heart of innovation.
Table of Contents
🖼️ The Standardisation of Clinical AI
️News:
🧬 Biotech
👁️ Tarsus Pharmaceuticals Acquires Alkeus for $450M in Retinal Disease Play: Tarsus acquired Alkeus Pharmaceuticals to expand its ophthalmic pipeline with gildeuretinol, a Phase 3 oral candidate for Stargardt disease.
📉 BioMarin Discontinues $270M Asset After Phase 3 Trial Failure: BioMarin terminated development of its late-stage metabolic therapy after it failed to meet key primary efficacy endpoints.
🤝 Incyte Nears $2B Acquisition Deal for Star Therapeutics: Incyte progressed toward acquiring privately held Star Therapeutics to expand its rare blood disorder and immunology franchise.
💔 Actimed Terminates $126M Deal with Faraday to Reclaim Cachexia Rights: Actimed brought global development rights for its muscle wasting disease candidate back in-house to lead Phase 2b trials.
🧬 Ensoma Trims Staff and Pauses Preclinical Genomic Programs: Ensoma announced a corporate restructuring, pausing early-stage gene therapy research to extend its operational runway.
💻 Digital Health
🎙️ CompliMind Expands Ambient Voice AI Across 15 NHS Hospital Trusts: Cambridge-based AI developer CompliMind scaled its clinical risk and documentation platform to cover over 10% of the UK NHS hospital estate.
🏥 Guy’s and St Thomas’ Inks Tech Partnership with Dräger Medical: Guy's and St Thomas' NHS Foundation Trust partnered with Dräger to codevelop connected ICU hardware and digital patient monitoring tools.
🏢 Nordic Opens Dedicated Nearshore Delivery Hub in Mexico: Healthcare IT services provider Nordic opened a new operational facility to expand AI implementation and EHR optimization services across health systems.
🛡️ Consint.AI Secures Series A Financing to Scale Healthcare Fraud Detection: Consint.AI raised new capital to expand its machine-learning software designed to detect automated insurance claim fraud globally.
🌐 RapidAI Outlines Scale and Integration Standards for Clinical AI: Imaging software provider RapidAI unveiled new platform integrations to standardize automated stroke and neurovascular triage across hospital networks.
⚖️ Regulatory Affairs
💉 FDA Approves Moderna's mFlusiva as First mRNA Flu Vaccine: The FDA granted approval to Moderna’s mFlusiva (mRNA-1010) for adults 50 and older, establishing the world's first mRNA-based seasonal influenza shot.
🧠 FDA Approves Takeda’s Orzeyful as First Disease-Modifying Narcolepsy Therapy: The FDA approved Takeda’s oral orexin receptor 2 agonist Orzeyful (oveporexton) to treat the root cause of Narcolepsy Type 1.
🦠 FDA Approves Replimune's Oncolytic Viral Therapy Tudriqev for Advanced Melanoma: The FDA granted accelerated approval to Replimune’s Tudriqev alongside BMS's Opdivo for patients progressing on prior anti-PD-1 therapies.
🩺 FDA VRBPAC Unanimously Recommends Approval Guidelines for mRNA Vaccines: The FDA’s vaccine advisory committee formally established updated immunogenicity framework criteria for multi-valent mRNA respiratory vaccines.
🩸 FDA Clears Expanded Labeling for Takeda's Subcutaneous Therapies: Regulators approved updated clinical administration protocols to allow home self-infusion across specialized rare disease portfolios.FDA Proposes Major Rule Overhaul to Modernize Global Drug Manufacturing Registrations: Federal regulators introduced a sweeping framework intended to digitize, clean, and aggressively enforce automated reporting standards for both domestic and foreign commercial pharmaceutical manufacturing facilities
🛒 Funding roundup:
Company / Partnership | Funding Amount | Focus Area | Location | Investors / Partners |
LifeMine Therapeutics | $188.0M (Series E) | Immunosuppressant therapeutics & organ transplant care | Cambridge, MA, US | Milky Way Investments, Bezos Expeditions, Gates Frontier, RA Capital Management, Google Ventures, LoLa Capital Partners, GSK, Invus, ARCH Venture Partners |
Expedition Therapeutics | $115.0M (Series B) | Respiratory disease & DPP1 inhibitor therapeutics | San Francisco, US | General Atlantic, RA Capital, Vivo Capital, Sofinnova Investments, Novo Holdings, Forbion, Dawn Biopharma, Adage Capital, Balyasny, Logos Capital, Sanofi Ventures, BVF Partners, Venrock |
$3.6M (Seed) | AI-powered radiology & diagnostic imaging | South Korea / Global | Early-stage healthtech & AI venture funds | |
MiiHealth AI | $2.8M (Seed) | AI patient intake & provider workflow platform | United States | Russell Glass (Arteria Capital), physician angels, healthcare operators, digital health founders |
BioNexus | Undisclosed (Seed) | AI scientist agents & drug discovery platform | South Korea / Global | Bass Ventures, SMB Investment Partners |
Endo Health | Undisclosed (Pre-Seed) | Digital diabetes care & management platform | Global | Early-stage digital health investors |
Healthcare AI standardisation is a double-edged sword
Enterprise platform updates from neuro-imaging leaders like RapidAI reflect a massive structural shift in digital health: moving past fragmented point-solution algorithms toward network-wide enterprise workflow standardization.
By embedding AI directly into existing PACS, EHRs, and mobile channels using vendor-agnostic protocols (DICOM, HL7, FHIR), enterprise clinical platforms are rebuilding the hub-and-spoke acute care model.
🙅The operational benefits are undeniable:
🔹 Hub-and-Spoke Equity: Rural "spoke" centers lacking 24/7 neuroradiologists get automated analysis in under 3 minutes, equalizing triage speed.
🔹 Dynamic Worklist Prioritization: Instead of living in isolated portals, urgent scans automatically bump to the top of native PACS queues.
🔹 Parallel Team Activation: Mobile notifications hit neurosurgeons, interventionalists, and ER doctors simultaneously. This reduces door-to-puncture times by over 30 minutes in thrombectomy cases.
⚠️However, standardizing AI across an entire health network centralizes risk.
As health system executives mandate these enterprise workflow engines across dozens of facilities, we must confront three critical realities:
⚖️ 1. The Liability Ambiguity When a standardized platform flags a scan as "negative" and a subtle, early-stage stroke is missed, where does the legal liability sit? Software vendors protect themselves behind "clinical decision support" disclaimers. Physicians reference mandatory system protocol. Health systems may be left with the liability when "standardized workflow" encounters human automation bias.
🔔 2. Alarm Fatigue vs. Automation Bias Parallel mobile alerts mobilize care teams quickly, but if the algorithm's sensitivity triggers constant high-priority alerts for low-grade findings, call teams quickly burn out. Conversely, set the bar too passively, and clinicians risk using a "negative" AI read to prematurely rule out complex, atypical pathology.
⚙️ 3. The Hardware Quality Gap An algorithm is only as good as the raw data fed into it. Standardizing software across a 20-hospital network sounds great in a board deck, but a rural "spoke" facility running an older CT scanner with suboptimal contrast timing will not yield the same algorithm sensitivity as a tertiary academic hub. Standardized software operating on un-standardized hardware is a recipe for false confidence.
Network-wide AI integration is essential for operational scale, but must have clear and unambiguous clinical governance that does not simply transfer liability to operators. True enterprise AI deployment requires clear legal liability frameworks, strict hardware baselines, and constant auditing for automation bias.
🏢Job Opportunities
Listed chronological order (latest at the end!).
When you apply tell the company you heard about the role @ The Fix! (Click for link to listing)
💡Customer Success Lead, Heidi (JP)
💡Head of Design System, Doctolib (FR)
💡Director, Privacy, Omada Health (US)
💡Lead Product Designer, Thriva (UK)
💡Senior Research Scientist, WHOOP (US)
💡Senior Manager, SingHealth Technology Incubator, SingHealth (SG)
💡Client Partner, Healthcare, Temus (SG)
💡Head of Product, NHS England (UK)
💡Clinical Product Lead, C the Signs (UK)
💡Change Project Manager (Clinical), Imperial College Health Partners (UK)
💡Senior Advisor (Core), Health Innovation East (UK)
💡Logistics manager, Advanced Ophthalmic Innovations Pte. Ltd. (SG)
💡Assistant Director, Health Services Research & Analytics, Ng Teng Fong General Hospital (SG)
💡Partner Manager, Global Health, Anthropic (US)
💡Expert Opportunity - Medical Science Liaison / Medical Affairs Professional, Ethos (SG)
💡Senior Product Designer, 9amHealth (US)
💡Director of Product, Oula (US)
💡Chief Product Officer, Viz.ai (US)
💡Solutions Lead, Healthcare, Protege (Remote)
💡Senior Product Manager, Sleep, WHOOP (US)
💡Director of Product Design, Runna (UK)
💡Senior Advisor (Core), Health Innovation East (UK)
💡Regulatory Affairs Lead, B1Neuro (SG)
💡Senior, Demand Generation and Account-Based Marketing, Amplify Health (SG)
💡Clinical Safety Officer, Healthtech-1 (UK)
💡Medical Director, Clinical Product, Counterpart Health Clover Health (US)
💡Clinical Director, Heidi (US remote)
💡VP of Clinical Services and Executive Medical Director, Solace Solace (US)
💡Content Writer, The Doctor's Kitchen The Doctor’s Kitchen (UK)
💡Clinical Engagement Specialist, Patchwork Health (UK)
💡Clinical Lead, Accurx (UK)
💡Clinical Safety Officer Doccla (UK)
💡Senior Director, Clinical Quality, Omada health (US)
💡Head of Clinical AI, Sanome (UK)
💡Senior Product Manager, Blue Health Intelligence (Netherlands)
💡Principal Software Engineer, Phlo (UK)
💡Senior Program Officer/Program Officer Path (india, Indonesia)
💡VP, Commercial, 52 North (UK)
💡Clinical Product Lead, C the Signs (UK)
🌆Upcoming Events
🍵Upcoming Tech Brews meetings
Singapore – Sat 15 Aug, 9:00AM "Sat Health & Bio Brews SG (networking)"
London – Sat 15 Aug, 9:00PM "From Clinical Problem to Health-Tech Venture"
Edinburgh - Aug 20, 5PM
Japan – Sat 22 Aug, 9:00AM "Japan Health/Bio Coffee Club Speaker: Rachel Lin"
Singapore – Sat 22 Aug, 9:00AM "Sat Health & Bio Brews SG (AMA)"
Mumbai– Sat 22 Aug, 9:00AM "Health & Bio Brews Mumbai Speaker: Aditya Daftary"
Singapore – Sat 29 Aug, 9:00AM "Sat Health & Bio Brews SG Speaker: "
Japan – Sat 29 Aug, 9:00AM "Japan Health/Bio Coffee Club Speaker: Wanping AW"
🌏 Global MedTech & Health Summits
August 20, 2026: Medical Fair China China Medical Fair China 2026 explores the next generation of medical technology, showcasing advances in AI, digital healthcare, surgical robotics, minimally invasive technologies, and global medtech innovation. The event brings together industry leaders, researchers, and clinicians to accelerate the translation of innovation into clinical practice and international growth. https://www.medicalfair.cn/en/about.html
August 21–23, 2026: India Health 2026 India Large-scale healthcare exhibition connecting global medical technology companies, healthcare providers, and industry leaders with India's rapidly growing healthcare ecosystem.
August 23-25, 2026: HIMMS APAC Singapore HIMSS26 APAC brings together healthcare leaders, government voices, clinicians, innovators, and technology partners from across the region to explore how health systems can move from AI ambition to evidence-based action. https://www.himss.org/events-overview/apac-conference-and-exhibition/overview
September 1, 2026: Asia Bio Partnering Forum Singapore The premier Asia-Pacific biopharma partnering conference, bringing together global life sciences leaders to foster cross-border collaborations, investment, licensing, and strategic partnerships across the region. https://informaconnect.com/asia-bio-partnering-forum/?gad_source=1&gad_campaignid=23883457671&gbraid=0AAAAADLlp5RLu1gQgINZIHnvee4k_pviB&gclid=CjwKCAjwuanRBhBSEiwAY5y6V0dyrzaeWq9ZplmvdAzO4b964WqOdnGbmBvWLTaxuDLK7P7AdnwokhoCxzoQAvD_BwE
September 14–16, 2026: WHX Dubai Tech Dubai, UAE One of the Middle East's largest healthcare technology exhibitions, showcasing innovations in digital health, medical devices, diagnostics, and healthcare infrastructure while connecting global healthcare leaders and innovators. https://www.worldhealthexpo.com/events/healthcare/dubai/en/home.html
September 14–17, 2026: Becker's Health IT + Digital Health + Revenue Cycle Management Conference Boston, USA Leading conference for healthcare executives focused on AI, digital transformation, interoperability, cybersecurity, revenue cycle management, and technology strategies that improve healthcare delivery and operational performance. https://conferences.beckershospitalreview.com/HIT_RCM_2026
September 16–17, 2026: LSX World Congress USA Boston, USA Premier life sciences partnering event bringing together biotech, medtech, pharmatech, investors, and pharmaceutical leaders to showcase innovation, build strategic partnerships, and shape the future of healthcare. https://informaconnect.com/lsx-world-congress-usa/
September 22–23, 2026: World Medical Innovation Forum Boston, USA Global forum convening healthcare leaders, innovators, researchers, investors, and policymakers to explore emerging opportunities, technologies, and challenges shaping the future of medical innovation.
Get your event listed here! Simply fill in the form here
Editorial: Terence Tan
Events & Opportunities: Eugene Fang
Disclaimers- Views, thoughts, and opinions expressed in the text belong solely to the author, and not necessarily to the author's employer, organization, committee or other group or individual. The above analysis is also purely personal opinion and should not be taken as professional advice. All content intended for informational purposes.
Disclosures- At the time of this post, The Fix or the team have not received any sponsorship, whether financial or in-kind for this post. There is no equity or financial stake in any of the private companies mentioned above
